Price T Rowe Associates Inc Caribou Biosciences, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 27,840 shares of CRBU stock, worth $46,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,840
Previous 23,952
16.23%
Holding current value
$46,771
Previous $40,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
52.6MCall Options Held
148KPut Options Held
70.7K-
Black Rock Inc. New York, NY6.95MShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$7.76 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$7.68 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.31MShares$7.24 Million0.49% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.36MShares$3.96 Million0.38% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $102M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...